Markets
Readmission on the Horizon: How EU funding can boost British biotech
In the second edition of Money Moves, we look at how European funding could help British biotechs during a challenging time on the market.
H2 2022 to see the decline of Covid-19 vaccines as forecasts decrease
Money moves: How the biotech market is weathering inflationary storms
Current and future players in the lupus market
Novo Nordisk submitting once-weekly insulin to FDA following Phase III success
Age-related macular degeneration market expected to grow to $22.8bn in 2031
